Want to take quizzes and track your credits?
What is the risk of spinal hematoma after lumbar puncture in patients with coagulopathy?
In this Danish registry-based cohort study that included 64 730 patients undergoing 83 711 individual lumbar punctures, the overall 30-day risk of spinal hematoma was 0.20% among patients without coagulopathy at the time of the procedure and 0.23% among patients with coagulopathy.
Although potentially limited by bias due to physicians selecting relatively low-risk patients for lumbar puncture, these findings provide estimates of the risk of spinal hematoma that may inform decision-making about lumbar puncture.
Coagulopathy may deter physicians from performing a lumbar puncture.
To determine the risk of spinal hematoma after lumbar puncture in patients with and without coagulopathy.
Design, Setting, and Participants
Danish nationwide, population-based cohort study using medical registries to identify persons who underwent lumbar puncture and had cerebrospinal fluid analysis (January 1, 2008-December 31, 2018; followed up through October 30, 2019). Coagulopathy was defined as platelets lower than 150 × 109/L, international normalized ratio (INR) greater than 1.4, or activated partial thromboplastin time (APTT) longer than 39 seconds.
Coagulopathy at the time of lumbar puncture.
Main Outcomes and Measures
Thirty-day risk of spinal hematoma. Risks were provided as numbers and percentages with 95% CIs. Secondary analyses included risks of traumatic lumbar puncture (>300 × 106 erythrocytes/L after excluding patients diagnosed with subarachnoid hemorrhage). Adjusted hazard rate ratios (HRs) were computed using Cox regression models.
A total of 83 711 individual lumbar punctures were identified among 64 730 persons (51% female; median age, 43 years [interquartile range, 22-62 years]) at the time of the procedure. Thrombocytopenia was present in 7875 patients (9%), high INR levels in 1393 (2%), and prolonged APTT in 2604 (3%). Follow-up was complete for more than 99% of the study participants. Overall, spinal hematoma occurred within 30 days for 99 of 49 526 patients (0.20%; 95% CI, 0.16%-0.24%) without coagulopathy vs 24 of 10 371 patients (0.23%; 95% CI, 0.15%-0.34%) with coagulopathy. Independent risk factors for spinal hematoma were male sex (adjusted hazard ratio [HR], 1.72; 95% CI, 1.15-2.56), those aged 41 through 60 years (adjusted HR, 1.96; 95% CI, 1.01-3.81) and those aged 61 through 80 years (adjusted HR, 2.20; 95% CI, 1.12-4.33). Risks did not increase significantly according to overall severity of coagulopathy, in subgroup analyses of severity of coagulopathy by pediatric specialty or medical indication (infection, neurological condition, and hematological malignancy), nor by cumulative number of procedures. Traumatic lumbar punctures occurred more frequently among patients with INR levels of 1.5 to 2.0 (36.8%; 95% CI, 33.3%-40.4%), 2.1 to 2.5 (43.7%; 95% CI, 35.8%-51.8%), and 2.6 to 3.0 (41.9% 95% CI 30.5-53.9) vs those with normal INR (28.2%; 95% CI, 27.7%-28.75%). Traumatic spinal tap occurred more often in patients with an APTT of 40 to 60 seconds (26.3%; 95% CI, 24.2%-28.5%) vs those with normal APTT (21.3%; 95% CI, 20.6%-21.9%) yielding a risk difference of 5.1% (95% CI, 2.9%-7.2%).
Conclusions and Relevance
In this Danish cohort study, risk of spinal hematoma following lumbar puncture was 0.20% among patients without coagulopathy and 0.23% among those with coagulopathy. Although these findings may inform decision-making about lumbar puncture by describing rates in this sample, the observed rates may reflect bias due to physicians selecting relatively low-risk patients for lumbar puncture.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Jacob Bodilsen, MD, Department of Infectious Diseases, Aalborg University Hospital, Mølleparkvej 4, 9000 Aalborg, Denmark (email@example.com).
Accepted for Publication: July 23, 2020.
Author Contributions: Dr Bodilsen had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Bodilsen.
Acquisition, analysis, or interpretation of data: Bodilsen, Mariager, Vestergaard, Christiansen, Kunwald, Bjarkam, Nielsen.
Drafting of the manuscript: Bodilsen.
Critical revision of the manuscript for important intellectual content: Bodilsen, Mariager, Vestergaard, Kunwald, Lüttichau, Kristensen, Bjarkam, Nielsen.
Statistical analysis: Bodilsen.
Administrative, technical, or material support: Bodilsen, Mariager, Kunwald, Nielsen.
Supervision: Lüttichau, Bjarkam, Nielsen.
Conflict of Interest Disclosures: None reported.
You currently have no searches saved.